Description: Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.
Home Page: www.cibus.com
6455 Nancy Ridge Drive
San Diego,
CA
92121
United States
Phone:
858 450 0008
Officers
| Name | Title |
|---|---|
| Mr. Rory Balfour Riggs M.B.A. | Co-Founder, CEO & Chairman |
| Dr. Peter Beetham B.Sc., Ph.D. | Co-Founder, President, COO & Director |
| Dr. Greg Gocal Ph.D. | Co-Founder, Chief Scientific Officer & Executive VP |
| Mr. Jason Stokes J.D. | Chief Legal Officer, General Counsel & Corporate Secretary |
| Ms. Rosa Cheuk Kim J.D. | Senior Vice President of Legal |
| Dr. James Radtke Ph.D. | Senior Vice President of Product Development |
| Mr. Tony Moran | Senior Vice President of International Development |
| Norm Sissons | Senior Vice President of Seed & Traits |
| Ms. Noel Sauer Ph.D. | Senior Vice President of Research |
| Mr. Sean O'Connor Ph.D. | Senior VP and President & CEO of Nucelis |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.9981 |
| Price-to-Sales TTM: | 30.6045 |
| IPO Date: | 2023-06-01 |
| Fiscal Year End: | December |
| Full Time Employees: | 183 |